Filing Flows › Comparisons › MDXG vs CERS
Mimedx Group vs Cerus: MDXG and CERS compared
Mimedx Group is the larger company: $62.3M of revenue in its latest quarter (Q3 2026) against $57.7M for Cerus (Q3 2026). Cerus is growing faster (+10% against -45% a year earlier). Cerus is more profitable, with an operating margin of 0.7% against -18.8%.
Where the money goes: MDXG and CERS
Mimedx Group (MDXG) · Q3 2026
Mimedx Group, Q3 2026: revenue $62.3M (-45% year over year), operating margin -18.8%, net loss $8.7M, operating cash flow $3.9M. The chart follows the revenue to costs, profit and cash.
Cerus (CERS) · Q3 2026
Cerus, Q3 2026: revenue $57.7M (+10% year over year), operating margin 0.7%, net loss $580K, operating cash flow $3.0M. The chart follows the revenue to costs, profit and cash.
| Mimedx Group (MDXG) | Cerus (CERS) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $62.3M | $57.7M |
| Revenue growth, Y/Y | -45% | +10% |
| Operating margin | -18.8% | 0.7% |
| Net earnings | −$8.7M | −$580K |
| Net margin | -13.9% | -1.0% |
| Operating cash flow | $3.9M | $3.0M |
| Free cash flow | $3.8M | $2.4M |
| Market value | $683M | — |
| Analysts’ mean target | $7.00 | — |
Where the revenue comes from
Mimedx Group
- Surgical: $40.0M (64%)
- Wound: $22.3M (36%)
Questions
Which is bigger, Mimedx Group or Cerus?
Mimedx Group is the larger company: $62.3M of revenue in its latest quarter (Q3 2026) against $57.7M for Cerus (Q3 2026).
Is Mimedx Group or Cerus growing faster?
Cerus is growing faster (+10% against -45% a year earlier).
Which is more profitable, Mimedx Group or Cerus?
Cerus is more profitable, with an operating margin of 0.7% against -18.8%.
More: Mimedx Group earnings · how Mimedx Group makes money · Cerus earnings · how Cerus makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Oct 28, 2026; 10-Q filed Nov 2, 2026). Fiscal quarters can end on different dates. Not investment advice.